These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 23872948

  • 1. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study.
    Eurich DT, Lee C, Marrie TJ, Majumdar SR.
    Clin Infect Dis; 2013 Oct; 57(8):1138-44. PubMed ID: 23872948
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [Abstract] [Full Text] [Related]

  • 3. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR.
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [Abstract] [Full Text] [Related]

  • 4. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 5. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia.
    Singanayagam A, Chalmers JD, Akram AR, Hill AT.
    Eur Respir J; 2011 Jul; 38(1):36-41. PubMed ID: 21429980
    [Abstract] [Full Text] [Related]

  • 6. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
    Lee TA, Weiss KB.
    Am J Respir Crit Care Med; 2004 Apr 01; 169(7):855-9. PubMed ID: 14711795
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
    Respir Med; 2009 Jan 01; 103(1):85-90. PubMed ID: 18793832
    [Abstract] [Full Text] [Related]

  • 8. Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and Risk of Pneumonia: A Nested Case-Control Population-based Study in Lazio (Italy)-The OUTPUL Study.
    Cascini S, Kirchmayer U, Belleudi V, Bauleo L, Pistelli R, Di Martino M, Formoso G, Davoli M, Agabiti N.
    COPD; 2017 Jun 01; 14(3):311-317. PubMed ID: 28406337
    [Abstract] [Full Text] [Related]

  • 9. Use of inhaled corticosteroids and the risk of tuberculosis.
    Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ.
    Thorax; 2013 Dec 01; 68(12):1105-13. PubMed ID: 23749841
    [Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS.
    Clin Respir J; 2008 Oct 01; 2(4):247-8. PubMed ID: 20298343
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
    Ferrer M, Torres A, Martínez R, Ramírez P, Polverino E, Montull B, Sialer S, Niederman MS, Agusti A, Menéndez R.
    Respirology; 2014 Aug 01; 19(6):929-35. PubMed ID: 24909304
    [Abstract] [Full Text] [Related]

  • 12. Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia.
    Sellares J, López-Giraldo A, Lucena C, Cilloniz C, Amaro R, Polverino E, Ferrer M, Menéndez R, Mensa J, Torres A.
    Am J Respir Crit Care Med; 2013 Jun 01; 187(11):1241-8. PubMed ID: 23590264
    [Abstract] [Full Text] [Related]

  • 13. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun 01; 11():1403-11. PubMed ID: 27382276
    [Abstract] [Full Text] [Related]

  • 14. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 01; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 15. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
    Wu MF, Jian ZH, Huang JY, Jan CF, Nfor ON, Jhang KM, Ku WY, Ho CC, Lung CC, Pan HH, Wu MC, Liaw YP.
    BMC Cancer; 2016 Oct 10; 16(1):778. PubMed ID: 27724847
    [Abstract] [Full Text] [Related]

  • 16. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
    O'Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S.
    Am J Respir Crit Care Med; 2011 Mar 01; 183(5):589-95. PubMed ID: 20889908
    [Abstract] [Full Text] [Related]

  • 17. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P, Gonzalez AV, Brassard P, Suissa S.
    Am J Respir Crit Care Med; 2007 Jul 15; 176(2):162-6. PubMed ID: 17400730
    [Abstract] [Full Text] [Related]

  • 18. Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer.
    Lee CH, Hyun MK, Jang EJ, Lee NR, Kim K, Yim JJ.
    Respir Med; 2013 Aug 15; 107(8):1222-33. PubMed ID: 23768737
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases.
    Brassard P, Suissa S, Kezouh A, Ernst P.
    Am J Respir Crit Care Med; 2011 Mar 01; 183(5):675-8. PubMed ID: 20889902
    [Abstract] [Full Text] [Related]

  • 20. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH, Perng DW, Chen CP, Chai WH, Yeh CS, Kor CT, Cheng SL, Chen JJ, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar 01; 11():3051-3058. PubMed ID: 27980402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.